BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

872 related articles for article (PubMed ID: 31072914)

  • 1. Silencing microRNA-27a inhibits proliferation and invasion of human osteosarcoma cells through the SFRP1-dependent Wnt/β-catenin signaling pathway.
    Mu Y; Zhang L; Chen X; Chen S; Shi Y; Li J
    Biosci Rep; 2019 Jun; 39(6):. PubMed ID: 31072914
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo and in vitro effects of microRNA-27a on proliferation, migration and invasion of breast cancer cells through targeting of SFRP1 gene via Wnt/β-catenin signaling pathway.
    Kong LY; Xue M; Zhang QC; Su CF
    Oncotarget; 2017 Feb; 8(9):15507-15519. PubMed ID: 28099945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-27a Promotes the Proliferation and Invasiveness of Colon Cancer Cells by Targeting SFRP1 through the Wnt/β-Catenin Signaling Pathway.
    Ba S; Xuan Y; Long ZW; Chen HY; Zheng SS
    Cell Physiol Biochem; 2017; 42(5):1920-1933. PubMed ID: 28772260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-27a-3p Modulates the Wnt/β-Catenin Signaling Pathway to Promote Epithelial-Mesenchymal Transition in Oral Squamous Carcinoma Stem Cells by Targeting SFRP1.
    Qiao B; He BX; Cai JH; Tao Q; King-Yin Lam A
    Sci Rep; 2017 Apr; 7():44688. PubMed ID: 28425477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Down-regulation of microRNA-31-5p inhibits proliferation and invasion of osteosarcoma cells through Wnt/β-catenin signaling pathway by enhancing AXIN1.
    Chen X; Zhong L; Li X; Liu W; Zhao Y; Li J
    Exp Mol Pathol; 2019 Jun; 108():32-41. PubMed ID: 30844369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-27a targets Sfrp1 to induce renal fibrosis in diabetic nephropathy by activating Wnt/β-Catenin signalling.
    Shi M; Tian P; Liu Z; Zhang F; Zhang Y; Qu L; Liu X; Wang Y; Zhou X; Xiao Y; Guo B
    Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32484208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MiRNA-27a promotes the proliferation and invasion of human gastric cancer MGC803 cells by targeting
    Wu F; Li J; Guo N; Wang XH; Liao YQ
    Am J Cancer Res; 2017; 7(3):405-416. PubMed ID: 28401000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of SOST Gene Silencing on Proliferation, Apoptosis, Invasion, and Migration of Human Osteosarcoma Cells Through the Wnt/β-Catenin Signaling Pathway.
    Zou J; Zhang W; Li XL
    Calcif Tissue Int; 2017 Jun; 100(6):551-564. PubMed ID: 28246931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-152 inhibits cell proliferation of osteosarcoma by directly targeting Wnt/β-catenin signaling pathway in a DKK1-dependent manner.
    Zhao X; Sun S; Xu J; Luo Y; Xin Y; Wang Y
    Oncol Rep; 2018 Aug; 40(2):767-774. PubMed ID: 29845282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MiR-27a regulates Wnt/beta-catenin signaling through targeting SFRP1 in glioma.
    Wang K; Xie D; Xie J; Wan Y; Ma L; Qi X; Yang S
    Neuroreport; 2015 Aug; 26(12):695-702. PubMed ID: 26164457
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MiR-1207 overexpression promotes cancer stem cell-like traits in ovarian cancer by activating the Wnt/β-catenin signaling pathway.
    Wu G; Liu A; Zhu J; Lei F; Wu S; Zhang X; Ye L; Cao L; He S
    Oncotarget; 2015 Oct; 6(30):28882-94. PubMed ID: 26337084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-27a promotes proliferation, migration and invasion by targeting MAP2K4 in human osteosarcoma cells.
    Pan W; Wang H; Jianwei R; Ye Z
    Cell Physiol Biochem; 2014; 33(2):402-12. PubMed ID: 24556602
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpressing circular RNA hsa_circ_0002052 impairs osteosarcoma progression via inhibiting Wnt/β-catenin pathway by regulating miR-1205/APC2 axis.
    Wu Z; Shi W; Jiang C
    Biochem Biophys Res Commun; 2018 Aug; 502(4):465-471. PubMed ID: 29852168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LncRNA DLG5-AS1 facilitates breast cancer cell proliferation and invasion by promoting EZH2-mediated transcriptional silencing of SFRP1.
    Cai Y; Liu Y; Sun Y; Ren Y
    Arch Biochem Biophys; 2024 Jun; 756():110018. PubMed ID: 38677505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Up-regulation of microRNA-340 promotes osteosarcoma cell apoptosis while suppressing proliferation, migration, and invasion by inactivating the CTNNB1-mediated Notch signaling pathway.
    Pan BL; Wu L; Pan L; Yang YX; Li HH; Dai YJ; He ZQ; Tan L; Huang YG; Tong ZW; Liao JL
    Biosci Rep; 2018 Aug; 38(4):. PubMed ID: 29769415
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CircMYO10 promotes osteosarcoma progression by regulating miR-370-3p/RUVBL1 axis to enhance the transcriptional activity of β-catenin/LEF1 complex via effects on chromatin remodeling.
    Chen J; Liu G; Wu Y; Ma J; Wu H; Xie Z; Chen S; Yang Y; Wang S; Shen P; Fang Y; Fan S; Shen S; Fang X
    Mol Cancer; 2019 Oct; 18(1):150. PubMed ID: 31665067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-340-5p suppresses osteosarcoma development by down-regulating the Wnt/β-catenin signaling pathway via targeting the STAT3 gene.
    Rongxin S; Pengfei L; Li S; Xiaochen J; Yihe H
    Eur Rev Med Pharmacol Sci; 2019 Feb; 23(3):982-991. PubMed ID: 30779064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Up-regulated lnc-SNHG1 contributes to osteosarcoma progression through sequestration of miR-577 and activation of WNT2B/Wnt/β-catenin pathway.
    Jiang Z; Jiang C; Fang J
    Biochem Biophys Res Commun; 2018 Jan; 495(1):238-245. PubMed ID: 29108989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of miR‑214 promotes the progression of human osteosarcoma by regulating the Wnt/β‑catenin signaling pathway.
    Zhu XB; Zhang ZC; Han GS; Han JZ; Qiu DP
    Mol Med Rep; 2017 Apr; 15(4):1884-1892. PubMed ID: 28260089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-506 inhibits tumor growth and metastasis in nasopharyngeal carcinoma through the inactivation of the Wnt/β-catenin signaling pathway by down-regulating LHX2.
    Liang TS; Zheng YJ; Wang J; Zhao JY; Yang DK; Liu ZS
    J Exp Clin Cancer Res; 2019 Feb; 38(1):97. PubMed ID: 30791932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 44.